Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Longum BCMC 02120 (1010), B.infantis BCMC 02129 (1010)Weight, BMI, WCNo significant changeHorvath, 2019 (36)/ Austria26, Both / 59.92P/ 12 &26Type 2/: Synbiotic: B. bifidum W23, B. lactis W51, B. lactis W52, L. acidophilus W37, L. casei W56, L. brevis W63, L. salivarius W24, L. lactis W58, L. lactis W19 (totally 1.5 × 1010)/ Galacto-oligosaccharides P11, Fructo-oligosaccharides P6 + konjac glucomannan P13 (E425), calcium carbonate (E170), zinc citrate 3-hydrate, vitamin D3 and vitamin B2 (E101)Weight, BMI, WC, HC, WHRSignificant decrease in HC in synbiotic group after 12 weeks of interventionHosseinzadeh, 2013 (53)/ Iran84, Both / 46.25P/ 121Type 2/: Brewer’s Yeast (1800 mg)BMINo significant changeHove, 2015 (37)/ Denmark41, M/ 59.42P/ 12Type 2/: Fermented milk: L. helveticus Cardi04Weight, BMI, WC, HCNo significant changeKanazawa, 2021(27)/ Japan86, Both/ 56P/ 24Type 2/: Synbiotic: 3.0 g dry powder containing at least 3 × 108 living L.paracasei YIT 9029 (strain Shirota:LcS) organisms, 3 × 108 living B.breve YIT 12,272 (BbrY) organisms, and 7.5 g GOS per dayBMINo significant changeKassaian, 2019 (54)/ Iran86, Both / 52.97P/ 12 &26Prediabetes/: Probiotic: L. acidophilus (1.5 × 109), B.bifidum (1.5 × 109), B. lactis (1.5 × 109), B. longum (1.5 × 109)Synbiotic: Inulin + L. acidophilus (1.5 × 109), B.bifidum (1.5 × 109), B. lactis (1.5 × 109), B. longum (1.5 × 109)BMINo significant changeKhalili, 2019 (38)/ Iran40, Both / 44.75P/ 8Type 2/: Probiotic: L. casei 01 (108)Weight, BMI, WC, WHRSignificant decrease in Weight, BMI, WC in probiotic groupKobyliak, 2018 (39)/ Ukraine53, Both / 54.28P/ 8Type 2/: Probiotic: Bifidobacterium (1 × 1011), Lactobacillus, Lactococcus (6 × 1011), Propionibacterium (3 × 1011)Weight, BMI, WCSignificant decrease in WC in probiotic group compared to placeboKooshki, 2015 (40)/ Iran43, Both / 54.88P/ 8Type 2/: Synbiotic: B. coagulants (1.5 × 107) + Fructo-oligosaccharidesWeight, BMISignificant decrease in weight and BMI in synbiotic group compared to placeboMadempudi, 2019 (41)/ India74, Both / 52.05P/ 122Type 2/: Probiotic: L. salivarius UBLS22, L. casei UBLC42, L. plantarum UBLP40, L. acidophilus UBLA34, B. breve UBBr01, B. coagulans Unique IS2 (totally 6 × 1010)WeightSignificant decrease in weight in probiotic group compared to placeboMafi, 2018 (42)/ Iran60, Both / 59.9P/ 12Type 1&2/ NephropathyProbiotic: L. acidophilus ZT-L1 (2 × 109), B.bifidum ZT-B1(2 × 109), L. reuteri ZT(2 × 109), L. fermentum ZT-L3(2 × 109)Weight, BMINo significant changeMiraghajani, 2017 (43)/ Iran40, Both / 55.25P/ 8Type 2/ NephropathyProbiotic soy milk: L. plantarum A7 (4 × 109)Weight, BMI, WHRNo significant changeMobini, 2017(44)/ Sweden44, Both / 65P/ 12Type 2/: Probiotic (Low & high dose): L. reuteri DSM 17,938 (108) or (1010)Weight, BMI, WC, Body fatSignificant increase in weightin low dose probiotic groupMohamadshahi, 2014 (45)/ Iran44, Both / 51P/ 8Type 2/: Probiotic yogurt: B.animalis subsp. lactis Bb12 (DSM 10,140), L. acidophilus La5 (Totally 11.1 × 108)Weight, BMI, WC, HC, WHR, Body fatNo significant changeMohseni, 2018 (46)/ Iran60, Both / 60.55P/ 12Type 1&2/ Diabetic foot ulcerProbiotic: L. acidophilus (2 × 109), L. casei (2 × 109), L.
Source: Study characteristics. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Systematic review.
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Effects of probiotic/synbiotic supplementation on body weight in patients with diabetes: a systematic review and meta-analyses of randomized-controlled trials
Source: Article title.
Effects of probiotic/synbiotic supplementation on body weight in patients with diabetes: a systematic review and meta-analyses of randomized-controlled trials
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Effects of probiotic/synbiotic supplementation on body weight in patients with diabetes: a systematic review and meta-analyses of randomized-controlled trials
Systematic review · BMC Endocrine Disorders · 2023
Original publication title
Effects of probiotic/synbiotic supplementation on body weight in patients with diabetes: a systematic review and meta-analyses of randomized-controlled trials
© The Author(s) 2023
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
The aim of the present study was to assess the effect of probiotic/synbiotic supplementation on anthropometric measures in adults with diabetes, independent of body weight.
Source: ObjectiveAbstract: What methods does the paper describe?
PubMed, Scopus, Web of Sciences and the Cochrane Library were searched for randomized controlled trials (RCTs) up until December 14, 2022. The effect sizes were pooled using an inverse-variance random-effects model. The methodological quality of studies as well as the quality of evidence was assessed using standard tools.
Source: MethodsAbstract: Results
Thirty-two RCTs met the established inclusion criteria. Overall, compared with the respective control groups, probiotic/synbiotic supplementation resulted in a significant reduction in body weight (weighted mean difference [WMD]: -0.50 kg; 95% CI: -0.83, -0.17; I2 = 79.8%, n = 27 studies]), body mass index (WMD: -0.24 kg/m2; 95% CI: -0.39, -0.09; I2 = 85.7%, n = 30 studies), and waist circumference (WMD: -0.90 cm; 95% CI: -1.13, -0.52; I2 = 0%, n = 11 studies).
However, hip circumference and waist to hip ratio were not significantly improved.
Source: ResultsAbstract: Conclusions
Our analysis revealed that probiotic/synbiotic supplementation may assist with weight management in patients with diabetes, especially when consumed at higher doses, in younger adults, and in participants with obesity. However, more studies are needed to elucidate the anti-obesity effects of specific strains of probiotics/synbiotics.
Source: ConclusionsAuthors’ abstract
Objective
The aim of the present study was to assess the effect of probiotic/synbiotic supplementation on anthropometric measures in adults with diabetes, independent of body weight.
Methods
PubMed, Scopus, Web of Sciences and the Cochrane Library were searched for randomized controlled trials (RCTs) up until December 14, 2022. The effect sizes were pooled using an inverse-variance random-effects model. The methodological quality of studies as well as the quality of evidence was assessed using standard tools.
Results
Thirty-two RCTs met the established inclusion criteria. Overall, compared with the respective control groups, probiotic/synbiotic supplementation resulted in a significant reduction in body weight (weighted mean difference [WMD]: -0.50 kg; 95% CI: -0.83, -0.17; I2 = 79.8%, n = 27 studies]), body mass index (WMD: -0.24 kg/m2; 95% CI: -0.39, -0.09; I2 = 85.7%, n = 30 studies), and waist circumference (WMD: -0.90 cm; 95% CI: -1.13, -0.52; I2 = 0%, n = 11 studies).
However, hip circumference and waist to hip ratio were not significantly improved.
Conclusions
Our analysis revealed that probiotic/synbiotic supplementation may assist with weight management in patients with diabetes, especially when consumed at higher doses, in younger adults, and in participants with obesity. However, more studies are needed to elucidate the anti-obesity effects of specific strains of probiotics/synbiotics.
Supplementary Information
The online version contains supplementary material available at 10.1186/s12902-023-01338-x.
Publication and source details
Original title: Effects of probiotic/synbiotic supplementation on body weight in patients with diabetes: a systematic review and meta-analyses of randomized-controlled trials
Sepideh Soltani; Marziyeh Ashoori; Fereshteh Dehghani; Fatemeh Meshkini; Zachary Stephen Clayton; Shima Abdollahi
BMC Endocrine Disorders · 2023
© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.North Khorasan University of Medical SciencesRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T19:37:58.690715+00:00
DOI: 10.1186/s12902-023-01338-x · PMC10120130